BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 14, 2017
View Archived Issues
Immunovaccine announces achievement in personalized cancer vaccine program
Read More
hKCC2 found as a novel target in traumatic brain injury
Read More
Vifor Pharma begins three studies in iron deficiency and heart failure
Read More
E-Scape Bio closes series A financing extension
Read More
OncoTherapy Science announces a new subsidiary company
Read More
Bayer tests novel thrombin inhibitor BAY-224 in thrombosis models
Read More
Sunovion sells U.S. rights to ciclesonide products to Covis Pharma
Read More
New mutations in F13B gene tied to mild FXIII deficiency
Read More
Viamet Pharmaceuticals wins FDA fast track designation for VT-1598
Read More
FDA accepts Pfizer's sNDA for Xeljanz in ulcerative colitis
Read More
Encouraging phase IIa results for DMX-200 in patients with proteinuria
Read More
Neuroprotective effects of co-ultraPEALut explored in model of vascular dementia
Read More
Gilead Sciences' MAA for bictegravir/emtricitabine/tenofovir alafenamide FDC validated by EMA
Read More
Chengdu Baiyu Ginkgolide Pharmaceuticals divulges ginkgolide B derivatives
Read More
Southern Research Institute identifies LRRK2 inhibitors
Read More
ShangPharma Innovation enters collaboration with UCSF
Read More
Raze Therapeutics discloses MTHFD2 inhibitors
Read More
Bioelectron Technology discloses hydroquinone derivatives for neurodegeneration
Read More
Bristol-Myers Squibb discovers CXCR4 antagonists
Read More
Aduro BioTech earns milestone in Merck & Co. collaboration
Read More
Tulane University receives grants from NIH to create Lassa vaccine and treatment
Read More
FDA agrees to add indication to Apexian Pharmaceuticals' IND for APX-3330
Read More
Mirikizumab named orphan drug for pediatric Crohn's disease in the U.S.
Read More
FDA approves Tremfya for moderate to severe plaque psoriasis
Read More
RNS-60 receives FDA orphan designation for amyotrophic lateral sclerosis
Read More
Novel ITGA2B gene mutations found in Glanzmann thrombasthenia
Read More
EMA validates pacritinib MAA for patients with myelofibrosis who have thrombocytopenia
Read More
FDA grants fast track designation to SB-318 and SB-913
Read More
MMRF selects Avista Pharma to manufacture component of opioid addiction vaccine
Read More
